BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 19185004)

  • 1. A missense mutation in ABCB4 gene involved in progressive familial intrahepatic cholestasis type 3 leads to a folding defect that can be rescued by low temperature.
    Delaunay JL; Durand-Schneider AM; Delautier D; Rada A; Gautherot J; Jacquemin E; Aït-Slimane T; Maurice M
    Hepatology; 2009 Apr; 49(4):1218-27. PubMed ID: 19185004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cellular, chemical, and pharmacological chaperones on the rescue of a trafficking-defective mutant of the ATP-binding cassette transporter proteins ABCB1/ABCB4.
    Gautherot J; Durand-Schneider AM; Delautier D; Delaunay JL; Rada A; Gabillet J; Housset C; Maurice M; Aït-Slimane T
    J Biol Chem; 2012 Feb; 287(7):5070-8. PubMed ID: 22184139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The spectrum of liver diseases related to ABCB4 gene mutations: pathophysiology and clinical aspects.
    Davit-Spraul A; Gonzales E; Baussan C; Jacquemin E
    Semin Liver Dis; 2010 May; 30(2):134-46. PubMed ID: 20422496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a Novel Missense Mutation in
    Saleem K; Cui Q; Zaib T; Zhu S; Qin Q; Wang Y; Dam J; Ji W; Liu P; Jia X; Wu J; Bai J; Fu S; Sun W
    Dis Markers; 2020; 2020():6292818. PubMed ID: 32626542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional analysis of ABCB4 mutations relates clinical outcomes of progressive familial intrahepatic cholestasis type 3 to the degree of MDR3 floppase activity.
    Gordo-Gilart R; Andueza S; Hierro L; Martínez-Fernández P; D'Agostino D; Jara P; Alvarez L
    Gut; 2015 Jan; 64(1):147-55. PubMed ID: 24594635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation of ABCB4 impacts its function: insights from disease-causing mutations.
    Gautherot J; Delautier D; Maubert MA; Aït-Slimane T; Bolbach G; Delaunay JL; Durand-Schneider AM; Firrincieli D; Barbu V; Chignard N; Housset C; Maurice M; Falguières T
    Hepatology; 2014 Aug; 60(2):610-21. PubMed ID: 24723470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization and structural implications of 25 new ABCB4 mutations in progressive familial intrahepatic cholestasis type 3 (PFIC3).
    Degiorgio D; Colombo C; Seia M; Porcaro L; Costantino L; Zazzeron L; Bordo D; Coviello DA
    Eur J Hum Genet; 2007 Dec; 15(12):1230-8. PubMed ID: 17726488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional characterization of ABCB4 mutations found in progressive familial intrahepatic cholestasis type 3.
    Park HJ; Kim TH; Kim SW; Noh SH; Cho KJ; Choi C; Kwon EY; Choi YJ; Gee HY; Choi JH
    Sci Rep; 2016 Jun; 6():26872. PubMed ID: 27256251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A female of progressive familial intrahepatic cholestasis type 3 caused by heterozygous mutations of ABCB4 gene and her cirrhosis improved after treatment of ursodeoxycholic acid: a case report.
    Qiao F; Ren F; Lu W; Yang H; Mo G; Wang S; Liu L; Xu X
    BMC Med Genomics; 2023 Jul; 16(1):171. PubMed ID: 37488596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABCB4: Insights from pathobiology into therapy.
    Falguières T; Aït-Slimane T; Housset C; Maurice M
    Clin Res Hepatol Gastroenterol; 2014 Oct; 38(5):557-63. PubMed ID: 24953525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A functional classification of ABCB4 variations causing progressive familial intrahepatic cholestasis type 3.
    Delaunay JL; Durand-Schneider AM; Dossier C; Falguières T; Gautherot J; Davit-Spraul A; Aït-Slimane T; Housset C; Jacquemin E; Maurice M
    Hepatology; 2016 May; 63(5):1620-31. PubMed ID: 26474921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mutation in the canalicular phospholipid transporter gene, ABCB4, is associated with cholestasis, ductopenia, and cirrhosis in adults.
    Gotthardt D; Runz H; Keitel V; Fischer C; Flechtenmacher C; Wirtenberger M; Weiss KH; Imparato S; Braun A; Hemminki K; Stremmel W; Rüschendorf F; Stiehl A; Kubitz R; Burwinkel B; Schirmacher P; Knisely AS; Zschocke J; Sauer P
    Hepatology; 2008 Oct; 48(4):1157-66. PubMed ID: 18781607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABCB4 heterozygous gene mutations associated with fibrosing cholestatic liver disease in adults.
    Ziol M; Barbu V; Rosmorduc O; Frassati-Biaggi A; Barget N; Hermelin B; Scheffer GL; Bennouna S; Trinchet JC; Beaugrand M; Ganne-Carrié N
    Gastroenterology; 2008 Jul; 135(1):131-41. PubMed ID: 18482588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The histidine-loop is essential for transport activity of human MDR3. A novel mutation of MDR3 in a patient with progressive familial intrahepatic cholestasis type 3.
    Dzagania T; Engelmann G; Häussinger D; Schmitt L; Flechtenmacher C; Rtskhiladze I; Kubitz R
    Gene; 2012 Sep; 506(1):141-5. PubMed ID: 22766396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional defect of variants in the adenosine triphosphate-binding sites of ABCB4 and their rescue by the cystic fibrosis transmembrane conductance regulator potentiator, ivacaftor (VX-770).
    Delaunay JL; Bruneau A; Hoffmann B; Durand-Schneider AM; Barbu V; Jacquemin E; Maurice M; Housset C; Callebaut I; Aït-Slimane T
    Hepatology; 2017 Feb; 65(2):560-570. PubMed ID: 28012258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ivacaftor-Mediated Potentiation of ABCB4 Missense Mutations Affecting Critical Motifs of the NBDs: Repositioning Perspectives for Hepatobiliary Diseases.
    Delaunay JL; Elbahnsi A; Bruneau A; Madry C; Durand-Schneider AM; Stary A; Housset C; Gautheron J; Callebaut I; Aït-Slimane T
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive familial intrahepatic cholestasis.
    Jacquemin E
    Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S26-35. PubMed ID: 23141890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterozygous ABCB4 mutations in children with cholestatic liver disease.
    Gordo-Gilart R; Hierro L; Andueza S; Muñoz-Bartolo G; López C; Díaz C; Jara P; Álvarez L
    Liver Int; 2016 Feb; 36(2):258-67. PubMed ID: 26153658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural analogues of roscovitine rescue the intracellular traffic and the function of ER-retained ABCB4 variants in cell models.
    Vauthier V; Ben Saad A; Elie J; Oumata N; Durand-Schneider AM; Bruneau A; Delaunay JL; Housset C; Aït-Slimane T; Meijer L; Falguières T
    Sci Rep; 2019 Apr; 9(1):6653. PubMed ID: 31040306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ABCB4 mutations in adult patients with cholestatic liver disease: impact and phenotypic expression.
    Degiorgio D; Crosignani A; Colombo C; Bordo D; Zuin M; Vassallo E; Syrén ML; Coviello DA; Battezzati PM
    J Gastroenterol; 2016 Mar; 51(3):271-80. PubMed ID: 26324191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.